The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The Flavanol (−)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced Toxicity
Open accessAbstract
Islet amyloid polypeptide (IAPP, amylin) is the major protein component of the islet amyloid deposits associated with type 2 diabetes. The polypeptide lacks a well-defined structure in its monomeric state but readily assembles to form amyloid. Amyloid fibrils formed from IAPP, intermediates generated in the assembly of IAPP amyloid, or both are toxic to β-cells, suggesting that islet amyloid formation may contribute to the pathology of type 2 diabetes. There are relatively few reported inhibitors of amyloid formation by IAPP. Here we show that the tea-derived flavanol, (-)-epigallocatechin 3-gallate [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate] (EGCG), is an effective inhibitor of in vitro IAPP amyloid formation and disaggregates preformed amyloid fibrils derived from IAPP. The compound is thus one of a very small set of molecules which have been shown to disaggregate IAPP amyloid fibrils. Fluorescence-detected thioflavin-T binding assays and transmission electron microscopy confirm that the compound inhibits unseeded amyloid fibril formation as well as disaggregates IAPP amyloid. Seeding studies show that the complex formed by IAPP and EGCG does not seed amyloid formation by IAPP. In this regard, the behavior of IAPP is similar to the reported interactions of Aβ and α-synuclein with EGCG. Alamar blue assays and light microscopy indicate that the compound protects cultured rat INS-1 cells against IAPP-induced toxicity. Thus, EGCG offers an interesting lead structure for further development of inhibitors of IAPP amyloid formation and compounds that disaggregate IAPP amyloid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions
Higdon, J. V., & Frei, B. (2003) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690390826464 · Cited by 1,854
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
An Analytical Solution to the Kinetics of Breakable Filament Assembly
Knowles, T. P. J., Waudby, C. A., Devlin, G. L., Cohen, S. I. A., Aguzzi, A., Vendruscolo, M., Terentjev, E. M., Welland, M. E., & Dobson, C. M. (2009) · Science · doi:10.1126/science.1178250 · Cited by 1,139
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., & Wanker, E. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910723107 · Cited by 1,011
Porat, Y., Abramowitz, A., & Gazit, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 989
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820
Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1521-05.2005 · Cited by 713
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 583
Comparison of alamar blue and MTT assays for high through-put screening
Hamid, R., Rotshteyn, Y., Rabadi, L., Parikh, R., & Bullock, P. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.03.012 · Cited by 570
Gurd, A., & Wilson, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91669-8 · Cited by 526
Clark, A., Wells, C. A., BULEY, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J. S., Holman, R. R., & Turner, R. C. (1988) · PubMed · Cited by 518
Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition
Collins, S. R., Douglass, A., Vale, R. D., & Weissman, J. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020321 · Cited by 515
Westermark, P., Wernstedt, C., Wilander, E., & Sletten, K. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90708-4 · Cited by 512
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Kahn, S. E., Andrikopoulos, S., & Verchere, C. B. (1999) · Diabetes · doi:10.2337/diabetes.48.2.241 · Cited by 488
Self-citationXue, W.-F., Homans, S. W., & Radford, S. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711664105 · Cited by 476
Rezai-Zadeh, K., Arendash, G. W., Hou, H., Fernandez, F., Jensen, M., Runfeldt, M., Shytle, R. D., & Tan, J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.107 · Cited by 459
Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., & Szarek, W. A. (1995) · Nature Medicine · doi:10.1038/nm0295-143 · Cited by 363
ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES
Clark, A., Lewis, C. E., Willis, A. C., Cooper, G. J. S., Morris, J. F., Reid, K. B. M., & Turner, R. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90825-7 · Cited by 350
COOPER, G. J. S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-2-163 · Cited by 297
Small-molecule aggregates inhibit amyloid polymerization
Feng, B. Y., Toyama, B. H., Wille, H., Colby, D. W., Collins, S. R., May, B. C. H., Prusiner, S. B., Weissman, J., & Shoichet, B. K. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.65 · Cited by 260
Thioflavine T interaction with amyloid β-sheet structures
LeVine, H. (1995) · Amyloid · doi:10.3109/13506129509031881 · Cited by 253
Yan, L.-M., Tatarek-Nossol, M., Velkova, A., Kazantzis, A., & Kapurniotu, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507471103 · Cited by 244
Peptide and Protein Mimetics Inhibiting Amyloid β-Peptide Aggregation
Takahashi, T., & Mihara, H. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000475 · Cited by 236
Jaikaran, E. T. A. S., Higham, C. E., Serpell, L. C., Zurdo, J., Gross, M., Clark, A., & Fraser, P. E. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4593 · Cited by 236
Porat, Y., Mazor, Y., Efrat, S., & Gazit, E. (2004) · Biochemistry · doi:10.1021/bi048582a · Cited by 226
The aggregation potential of human amylin determines its cytotoxicity towards islet β‐cells
Konarkowska, B., Aitken, J. F., Kistler, J., Zhang, S., & Cooper, G. J. S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05367.x · Cited by 219
Islet amyloid polypeptide and type 2 diabetes
Marzban, L. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00004-4 · Cited by 201
Blazer, L. L., & Neubig, R. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.151 · Cited by 197
Abedini, A., & Raleigh, D. P. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp036 · Cited by 192
Self-citationHutton, J. C. (1989) · Diabetologia · doi:10.1007/bf00265542 · Cited by 191
Widespread Amyloid Deposition in Transplanted Human Pancreatic Islets
Westermark, G. T., Westermark, P., Berne, C., & Korsgren, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0802893 · Cited by 188
Abedini, A., Meng, F., & Raleigh, D. P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072157y · Cited by 177
Self-citationIslet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts
Potter, K. J., Abedini, A., Marek, P., Klimek, A. M., Butterworth, S., Driscoll, M., Baker, R., Nilsson, M. R., Warnock, G. L., Oberholzer, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909024107 · Cited by 168
Self-citationSipe, J. D., & Cohen, A. S. (1994) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369409084679 · Cited by 165
The Role of His-18 in Amyloid Formation by Human Islet Amyloid Polypeptide
Abedini, A., & Raleigh, D. P. (2005) · Biochemistry · doi:10.1021/bi051432v · Cited by 159
Self-citationNilsson, M. R., & Raleigh, D. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3286 · Cited by 150
Self-citationIslet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits.
Nishi, M., Sanke, T., Nagamatsu, S., Bell, G. I., & Steiner, D. F. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39539-0 · Cited by 141
Hudson, S. A., Ecroyd, H. W., Dehle, F. C., Musgrave, I., & Carver, J. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.031 · Cited by 141
Inhibiting Islet Amyloid Polypeptide Fibril Formation by the Red Wine Compound Resveratrol
Mishra, R., Sellin, D., Radovan, D., Gohlke, A., & Winter, R. (2009) · ChemBioChem · doi:10.1002/cbic.200800762 · Cited by 134
Alzhemed: A Potential Treatment for Alzheimers Disease
Aisen, P. S. S., Gauthier, S. G., Vellas, B. J., Briand, R., Saumier, D., Laurin, J., & Garceau, D. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788882 · Cited by 116
Abedini, A., & Raleigh, D. P. (2005) · Organic Letters · doi:10.1021/ol047480+ · Cited by 114
Self-citationThe Mechanism of Insulin Action on Islet Amyloid Polypeptide Fiber Formation
Larson, J. L., & Miranker, A. D. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.045 · Cited by 112
Small‐Molecule Inhibitors of Islet Amyloid Polypeptide Fibril Formation
Mishra, R., Bulic, B., Sellin, D., Jha, S., Waldmann, H., & Winter, R. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705372 · Cited by 112
A synergistic small-molecule combination directly eradicates diverse prion strain structures
Roberts, B. E., Duennwald, M. L., Wang, H., Chung, C., Lopreiato, N. P., Sweeny, E. A., Knight, M. N., & Shorter, J. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.246 · Cited by 107
Meng, F., Marek, P., Potter, K. J., Verchere, C. B., & Raleigh, D. P. (2008) · Biochemistry · doi:10.1021/bi702518m · Cited by 95
Self-citationLin, C., Chen, T., Chiu, M., Way, T., & Lin, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.012 · Cited by 89
Röcken, C., LINKE, R. P., & Saeger, W. (1992) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01660981 · Cited by 81
Abedini, A., Singh, G., & Raleigh, D. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.11.029 · Cited by 78
Self-citationUdayasankar, J., Kodama, K., Hull, R. L., Zraika, S., Aston‐Mourney, K., Subramanian, S. L., Tong, J., Faulenbach, M. V., Vidal, J., & Kahn, S. E. (2008) · Diabetologia · doi:10.1007/s00125-008-1185-7 · Cited by 71
Ling, Y. L., Strasfeld, D. B., Shim, S., Raleigh, D. P., & Zanni, M. T. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp810261x · Cited by 71
Self-citationBiological Properties of Monomeric and Polymeric Catechins: Green Tea Catechins and Procyanidins
Jeong, W., & Kong, A. T. (2004) · Pharmaceutical Biology · doi:10.3109/13880200490893500 · Cited by 62
Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice
Westermark, G. T., Westermark, P., Nordin, A., Törnelius, E., & Andersson, A. (2003) · Upsala Journal of Medical Sciences · doi:10.3109/2000-1967-113 · Cited by 50
Masuda, M., Hasegawa, M., Nonaka, T., Oikawa, T., Yonetani, M., Yamaguchi, Y., Kato, K., Hisanaga, S., & Goedert, M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.037 · Cited by 43
Li, Q., Gordon, M. N., Tan, J., & Morgan, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.062 · Cited by 21
Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes
Scrocchi, L. A., Chen, Y., Wang, F., Han, K. A., Ha, K., Wu, L., & Fraser, P. E. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442587 · Cited by 15
Cited by
Li, J., McQuade, T., Siemer, A. B., Napetschnig, J., Moriwaki, K., Hsiao, Y.-S., Damko, E., Moquin, D., Walz, T., McDermott, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.019 · Cited by 1,222
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Protein misfolding and aggregation in cataract disease and prospects for prevention
Moreau, K. L., & King, J. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.005 · Cited by 450
Targeting protein aggregation for the treatment of degenerative diseases
Eisele, Y. S., Monteiro, C., Fearns, C., Encalada, S. E., Wiseman, R. L., Powers, E. T., & Kelly, J. W. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4593 · Cited by 419
Review on Alzheimer’s Disease: Inhibition of Amyloid Beta and Tau Tangle Formation
Ashrafian, H., Zadeh, E. H., & Khan, R. H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.192 · Cited by 368
Metadata
- Authors
- Meng, F., Abedini, A., Plesner, A., Verchere, C. B., & Raleigh, D. P.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-08-30
- Volume
- 49
- Issue
- 37
- Pages
- 8127-8133
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1982653993
- Cited by
- 282
- References
- 59
- FWCI
- 11.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.